| |
| |
|
| Insider
Information: |
Arbuckle Stuart A |
| Relationship: |
Director |
| City: |
Cambridge, |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
62,795 |
|
|
Indirect Shares
|
140 |
|
|
| Direct
Value |
$22,712,016 |
|
|
|
Indirect Value
|
$63,973 |
|
|
| Total
Shares |
62,935 |
|
|
| Total
Value |
$22,775,989 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
• – – |
2020-02-06 |
4 |
AS |
$238.71 |
$667,253 |
D/D |
(2,787) |
67,563 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2024-02-20 |
4 |
D |
$420.58 |
$1,418,616 |
D/D |
(3,373) |
67,846 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-02-21 |
4 |
AS |
$291.01 |
$705,596 |
D/D |
(2,402) |
68,705 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
• – – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
34,778 |
69,957 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
• – – |
2021-02-03 |
4 |
AS |
$211.22 |
$332,146 |
D/D |
(1,554) |
69,957 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
• – – |
2020-02-06 |
4 |
OE |
$155.57 |
$483,559 |
D/D |
2,787 |
70,350 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-02-17 |
4 |
D |
$292.85 |
$1,317,239 |
D/D |
(4,498) |
71,107 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2024-02-16 |
4 |
D |
$424.01 |
$1,907,621 |
D/D |
(4,499) |
71,219 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
• – – |
2021-02-03 |
4 |
OE |
$86.52 |
$134,452 |
D/D |
1,554 |
71,511 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
35,535 |
71,937 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-02-17 |
4 |
D |
$232.51 |
$959,336 |
D/D |
(4,126) |
72,312 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
18,186 |
74,742 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-02-14 |
4 |
AS |
$295.84 |
$1,910,962 |
D/D |
(6,398) |
75,605 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2024-02-12 |
4 |
AS |
$420.24 |
$1,804,931 |
D/D |
(4,295) |
75,718 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-02-10 |
4 |
D |
$237.74 |
$722,730 |
D/D |
(3,040) |
76,438 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,375 |
79,478 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2024-02-09 |
4 |
D |
$422.74 |
$1,343,045 |
D/D |
(3,177) |
80,013 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-02-13 |
4 |
AS |
$296.44 |
$1,460,816 |
D/D |
(4,887) |
82,003 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
8,448 |
83,190 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-02-13 |
4 |
D |
$298.26 |
$1,786,577 |
D/D |
(5,990) |
86,890 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-02-10 |
4 |
D |
$294.33 |
$992,481 |
D/D |
(3,372) |
92,880 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,221 |
96,252 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-11-16 |
4 |
AS |
$121.95 |
$504,852 |
D/D |
(4,077) |
104,464 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-12-04 |
4 |
AS |
$123.53 |
$561,748 |
D/D |
(4,531) |
104,464 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-10-30 |
4 |
AS |
$123.36 |
$1,298,794 |
D/D |
(10,350) |
104,748 |
0 |
- |
|
192 Records found
|
|
Page 6 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
